Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.710
+0.130 (5.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lisata Therapeutics Employees
Lisata Therapeutics had 25 employees as of December 31, 2023. The number of employees decreased by 2 or -7.41% compared to the previous year.
Employees
25
Change (1Y)
-2
Growth (1Y)
-7.41%
Revenue / Employee
n/a
Profits / Employee
-$829,600
Market Cap
22.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bionano Genomics | 344 |
Athira Pharma | 67 |
Equillium | 44 |
VSee Health | 40 |
American Shared Hospital Services | 31 |
Pulmatrix | 22 |
Cocrystal Pharma | 12 |
Ocean Biomedical | 9 |
LSTA News
- 11 days ago - Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial - GlobeNewsWire
- 4 weeks ago - Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year' - GlobeNewsWire
- 5 weeks ago - Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration - GlobeNewsWire
- 6 weeks ago - Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024 - GlobeNewsWire
- 7 weeks ago - Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - GlobeNewsWire
- 7 weeks ago - Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - GlobeNewsWire